Trade press release
GEA: New tablet press with high throughput presented
June 26, 2024
GEA Pharma & Healthcare has now introduced the latest member of the NexGen Press® family. As a reliable supplier of state-of-the-art tableting equipment, the NexGen Press® range represents the future of tablet compression for the pharmaceutical industry. The experts at GEA have combined the best aspects of their existing equipment to create a family of machines that represent the next generation of tablet compression.
"We are on a mission to revolutionise the way businesses operate, using cutting-edge technologies and sustainable processes to increase productivity and minimise environmental impact," said Dr Jim Holman, Senior Director for Technology Management, Solid Dosage, at GEA: “Our mission is to revolutionize the way businesses operate by leveraging cutting-edge technologies and sustainable practices to enhance productivity and minimize environmental impact,” said Dr Jim Holman, Senior Director for Technology Management, Solid Dosage, at GEA: “We believe in the power of transformation to meet the demands of the present and to shape the world of tomorrow.”
Building on the Add Better label-winning NexGen Press® 30, the larger NexGen Press® 45 offers the same benefits as its smaller sibling, such as the flexibility to adapt to any containment level (up to OEB5) — thanks to the FAST CHANGEOVER Exchangeable Compression Module (FCO ECM). It can also be equipped with the same option packs, making it an extremely agile production system that can be tailored to accommodate a wide range of tableting applications (MUPS, bilayer, poorly flowing products, high yield, microtablets, etc.) and/or different cleaning strategies (wash offline or inline). In addition, every machine in the NexGen® Press range is equipped with six compression modes and benefits from GEA’s unique Air Compensator technology, effectively reducing common compression issues.
“With a maximum output capacity of more the 500,000 tablets per hour, this high-speed large-scale machine is a significant addition to the NexGen Press® portfolio,” Jim commented.
#TalkingPharma
Dr. Michael Golek
About GEA
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German MDAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.
